Faculty of Sports Science, Ningbo University, Zhejiang, China.
Centre for Health and Exercise Science Research, Department of Sport, Physical Education and Health, Hong Kong Baptist University, Kowloon Tong, Hong Kong SAR, China.
Front Immunol. 2021 Dec 22;12:761382. doi: 10.3389/fimmu.2021.761382. eCollection 2021.
The COVID-19 pandemic has led to several pioneering scientific discoveries resulting in no effective solutions with the exception of vaccination. Moderate exercise is a significant non-pharmacological strategy, to reduce the infection-related burden of COVID-19, especially in patients who are obese, elderly, and with additional comorbidities. The imbalance of T helper type 1 (Th1) or T helper type 2 (Th2) cells has been well documented among populations who have suffered as a result of the COVID-19 pandemic, and who are at maximum risk of infection and mortality. Moderate and low intensity exercise can benefit persons at risk from the disease and survivors by favorable modulation in Th1/Th2 ratios. Moreover, in COVID-19 patients, mild to moderate intensity aerobic exercise also increases immune system function but high intensity aerobic exercise may have adverse effects on immune responses. In addition, sustained hypoxia in COVID-19 patients has been reported to cause organ failure and cell death. Hypoxic conditions have also been highlighted to be triggered in COVID-19-susceptible individuals and COVID-19 survivors. This suggests that hypoxia inducible factor (HIF 1α) might be an important focus for researchers investigating effective strategies to minimize the effects of the pandemic. Intermittent hypoxic preconditioning (IHP) is a method of exposing subjects to short bouts of moderate hypoxia interspersed with brief periods of normal oxygen concentrations (recovery). This methodology inhibits the production of pro-inflammatory factors, activates HIF-1α to activate target genes, and subsequently leads to a higher production of red blood cells and hemoglobin. This increases angiogenesis and increases oxygen transport capacity. These factors can help alleviate virus induced cardiopulmonary hemodynamic disorders and endothelial dysfunction. Therefore, during the COVID-19 pandemic we propose that populations should engage in low to moderate exercise individually designed, prescribed and specific, that utilizes IHP including pranayama (yoga), swimming and high-altitude hiking exercise. This would be beneficial in affecting HIF-1α to combat the disease and its severity. Therefore, the promotion of certain exercises should be considered by all sections of the population. However, exercise recommendations and prescription for COVID-19 patients should be structured to match individual levels of capability and adaptability.
新型冠状病毒肺炎(COVID-19)大流行带来了一些开创性的科学发现,但除了疫苗接种外,没有其他有效的解决方案。适度运动是一种重要的非药物策略,可以减轻 COVID-19 的感染负担,特别是在肥胖、老年和伴有其他合并症的患者中。COVID-19 大流行期间,人群中 Th1 型(Th1)或 Th2 型(Th2)辅助性 T 细胞失衡的现象已有充分记载,这些人面临最大的感染和死亡风险。适度和低强度运动可以通过 Th1/Th2 比例的有利调节使疾病风险人群和幸存者受益。此外,在 COVID-19 患者中,轻度至中度强度的有氧运动也可以增强免疫系统功能,但高强度有氧运动可能对免疫反应产生不利影响。此外,据报道,COVID-19 患者的持续低氧会导致器官衰竭和细胞死亡。还强调 COVID-19 易感个体和 COVID-19 幸存者会出现低氧状态。这表明缺氧诱导因子(HIF 1α)可能是研究人员研究减轻大流行影响的有效策略的一个重要焦点。间歇性低氧预处理(IHP)是一种使受试者暴露于短暂的中度低氧中,中间穿插短暂的正常氧浓度(恢复期)的方法。这种方法抑制了促炎因子的产生,激活了 HIF-1α 以激活靶基因,随后导致红细胞和血红蛋白的产生增加。这增加了血管生成并提高了氧气输送能力。这些因素可以帮助缓解病毒引起的心肺血液动力学障碍和内皮功能障碍。因此,在 COVID-19 大流行期间,我们建议人群应根据个人情况进行低至中等强度的运动,包括 IHP 在内的运动,如呼吸法(瑜伽)、游泳和高海拔徒步旅行等运动。这将有利于对抗疾病及其严重程度的 HIF-1α。因此,应该考虑让所有人群都进行某些运动。然而,应该根据 COVID-19 患者的个体能力和适应性来构建运动建议和处方。